The main thing about P2P meth is that there’s so much of it (2021)

In 2021, P2P (phenylacetone) methamphetamine became the dominant form of meth in the United States, replacing older ephedrine-based methods. This shift affects drug potency, purity, and potentially the mental health outcomes of users, making it a significant development in the drug landscape.

Data from the Drug Enforcement Administration (DEA) shows that by 2021, the majority of meth seized in the US was produced via P2P synthesis, a method that became prevalent after regulations limited ephedrine and pseudoephedrine sales around 2006-2008. P2P meth is often associated with higher purity levels, averaging around 95% d-meth, the active isomer responsible for euphoric effects.

Research indicates that P2P synthesis can produce a mixture of d-meth and l-meth, with the latter having minimal psychoactive effects. However, by 2019, the proportion of l-meth in seized samples had decreased significantly, suggesting that manufacturing methods have evolved to favor d-meth production. The shift to P2P also introduced concerns about contaminants and impurities, though modern street meth is notably purer than in previous years.

Why It Matters

This development matters because the dominance of P2P meth has implications for public health, law enforcement, and addiction treatment. Higher purity and potency may increase risks of overdose and adverse mental health effects, especially given reports linking P2P meth to more sinister, isolating user experiences. Additionally, the change in manufacturing routes complicates enforcement and interdiction efforts.

Background

Historically, meth was produced from ephedrine or pseudoephedrine, with the US banning over-the-counter sales in 2006. In response, meth cooks shifted to P2P synthesis, which uses more readily available chemicals. Data from the DEA shows a rapid increase in P2P-based meth production starting around 2009, becoming the primary method by 2012. Over the years, manufacturing techniques have varied, with shifts between different precursor chemicals and synthesis routes, reflecting ongoing adaptations by illicit producers.

“The main thing about P2P meth is that there’s so much of it in 2021.”

— Sam Quinones

“Synthesis methods for P2P meth have changed repeatedly over the past decade, with different precursor chemicals and techniques.”

— DEA scientist

What Remains Unclear

While data confirms the rise of P2P meth and its high purity levels, details about the specific impact on user health, the full scope of manufacturing methods, and the presence of contaminants remain unclear. The extent of the influence of different synthesis routes on drug effects is still under investigation.

What’s Next

Law enforcement and public health agencies will continue monitoring trends in meth production, with increased focus on understanding health impacts and disrupting supply chains. Further research is expected to clarify the effects of P2P meth on users and to develop strategies for prevention and treatment.

Key Questions

Why did meth production shift to P2P synthesis?

The shift occurred mainly because regulations limited access to ephedrine and pseudoephedrine, prompting illicit producers to adopt P2P methods that use more available chemicals.

How does P2P meth differ from older ephedrine-based meth?

P2P meth often has higher purity, with a higher percentage of the active d-meth isomer, and may have different effects on mental health and behavior. It can also be associated with more contaminants depending on manufacturing methods.

What are the potential health risks associated with P2P meth?

Higher purity and potency increase overdose risks, and some reports suggest P2P meth may cause more severe mental health issues, including paranoia and hallucinations, though research is ongoing.

Is all P2P meth the same chemically?

No. The synthesis methods and precursor chemicals can vary, leading to differences in impurities and possibly in effects. The specific manufacturing route influences the final product’s composition.